A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression

As a pivotal vesicular trafficking protein, Myoferlin (MYOF) has become an attractive target for cancer therapy. However, the roles of MYOF in colorectal cancer invasion remain enigmatic, and MYOF‐targeted therapy in this malignancy has not been explored. In the present study, we provided the first...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yuan, Kan, Weiqiong, Li, Yunqi, Hao, Yun, Huang, Anling, Gu, Haijun, Wang, Minna, Wang, Qingqing, Chen, Jinlian, Sun, Zhenliang, Liu, Mingyao, Chen, Yihua, Yi, Zhengfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868085/
https://www.ncbi.nlm.nih.gov/pubmed/33634965
http://dx.doi.org/10.1002/ctm2.289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868085/
https://www.ncbi.nlm.nih.gov/pubmed/33634965
http://dx.doi.org/10.1002/ctm2.289

Ejemplares similares